SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Revenue of top domestic pharmaceutical firms to grow by 7-9% in current fiscal: Icra

26 Jul 2023 Evaluate

Rating agency Icra has said that revenue of top domestic pharmaceutical companies is likely to grow by 7-9 per cent in the current fiscal (FY24). It noted the growth will be supported by an 8-10 per cent expansion in the domestic market and a 6-8 per cent rise in the US market, while revenues from the European and emerging markets are expected to increase by 3-5 per cent and 8-10 per cent, respectively.

Agency said it has taken into account a sample set of 25 Indian drug firms, which constitute 60 per cent of the overall domestic industry. Further, it said that a continued focus on complex generics/speciality launches in the US market is expected to support industry margins in FY2024. It added the overall credit profile of Indian pharmaceutical companies is expected to remain healthy, supported by their stable earnings profile, comfortable leverage and coverage metrics, and strong liquidity position.

Icra Assistant Vice President & Sector Head Mythri Macherla said ‘The 8-10 per cent growth in the domestic market in FY24 will be supported by a WPI-linked price hike of 12.1 per cent allowed for products under the National List of Essential Medicines (NLEM), new product introductions and annual price hikes for non-NLEM products.  


About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×